Impulse control disorders
Important: Impulse control disorders (ICDs) can develop in a person with Parkinsonโs disease on any dopaminergic therapy, at any stage of the disease.
๐ง About
- ICDs are a recognised complication of Parkinsonโs treatment, most strongly linked with dopamine agonists but can occur with levodopa too.
- They represent maladaptive reward-seeking behaviours triggered by overstimulation of mesolimbic dopaminergic pathways.
๐ Clinical Presentation
- Pathological Gambling ๐ฐ
- Hypersexuality โค๏ธโ๐ฅ
- Compulsive Shopping ๐๏ธ
- Binge Eating ๐ซ
- Punding ๐ง โ stereotyped, repetitive handling of objects (e.g., disassembling gadgets, sorting items, skin-picking).
๐ Common Causative Medications
- Levodopa/Benserazide (Madopar)
- Typical daily dose: 300โ800 mg levodopa (divided).
- Started at 50โ100 mg tds, titrated gradually.
- Levodopa/Carbidopa (Sinemet)
- Typical daily dose: 300โ1,000 mg levodopa (divided).
- Common start: 100/25 mg tds.
- Dopamine Agonists
- Pramipexole: start 0.125โ0.25 mg tds, titrate up to ~1.5 mg tds.
- Ropinirole: start 0.25 mg tds, titrate up to ~8 mg tds.
- Rotigotine patch: start 2 mg/24h, titrate to 8 mg/24h (or more).
๐ ๏ธ Management of ICDs
- Medication Adjustment
- Reduce or stop the dopamine agonist first (most strongly associated).
- Rebalance Parkinsonโs drug regimen (consider levodopa dominance, COMT inhibitors, MAO-B inhibitors).
- Non-Pharmacological Support
- Cognitiveโbehavioural therapy for compulsive behaviours.
- Family education & close monitoring for relapse.
- Lifestyle and psychosocial interventions to reduce triggers.
Pearl for exams ๐: If a Parkinsonโs patient develops sudden gambling, hypersexuality, or compulsive spending, always suspect dopamine agonists and adjust medication.